📰 Teva Ajovy News
Teva Ajovy News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Teva Ajovy. Real-time updates on events, politics, business and more.
October 12, 2021
/PRNewswire/ -- Following the May 2021 FDA approval of Biohavens Nurtec ODT for the preventive treatment of episodic migraine, primary care physicians (PCPs)...
August 26, 2021
University of Tennessee researchers found that the peptides behind migraine pain can trigger insulin production in mice, and the study could lead to better methods for preventing or treating diabetes.
May 6, 2021
Oral Gepants Have Disrupted Acute Migraine Management and Look Next to Transform Preventive Treatment, According to Both Primary Care Physicians and Specialists New research from Spherix Global Insights finds the impressive uptake of AbbVies Ubrelvy and Biohavens Nurtec ODT appears to have already blunted reliance on the subcutaneous CGRP monoclonal antibodies, with growth of Amgen/Novartis Aimovig, Tevas Ajovy, and Eli Lillys Emgality all moderating News provided by Share this article Share th...